Cutaneous vasculitis: a rheumatologist perspective
- PMID: 23832592
- DOI: 10.1007/s11882-013-0367-7
Cutaneous vasculitis: a rheumatologist perspective
Abstract
Cutaneous vasculitis (CV) comprises a wide spectrum of diseases and displays a variety of clinical lesions, the most common being a palpable purpura. CV may be a process confined exclusively to the skin or be a manifestation of a more widespread entity associated to a variable grade of visceral involvement. In this regard, CV may occur as part of the clinical spectrum of primary systemic vasculitis, autoimmune diseases or less commonly as presenting manifestation of cancer or severe infections. An adequate clinical approach is required to establish optimal management of this condition.
Similar articles
-
Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients.Medicine (Baltimore). 1998 Nov;77(6):403-18. doi: 10.1097/00005792-199811000-00007. Medicine (Baltimore). 1998. PMID: 9854604 Review.
-
Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients.Medicine (Baltimore). 2004 Mar;83(2):96-106. doi: 10.1097/01.md.0000119465.24818.98. Medicine (Baltimore). 2004. PMID: 15028963
-
Vasculitis associated with primary rheumatologic diseases.Curr Opin Rheumatol. 1998 Jan;10(1):58-65. doi: 10.1097/00002281-199801000-00009. Curr Opin Rheumatol. 1998. PMID: 9448991 Review.
-
Primary vasculitides and vasculitis confined to skin: clinical features and new pathogenic aspects.Arch Dermatol Res. 2000 Sep;292(9):427-36. doi: 10.1007/s004030000163. Arch Dermatol Res. 2000. PMID: 11000286 Review.
-
Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2016 Dec 12;34(51):6561-6571. doi: 10.1016/j.vaccine.2016.09.032. Epub 2016 Oct 28. Vaccine. 2016. PMID: 28029543 Review. No abstract available.
Cited by
-
Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis.Rheumatol Int. 2015 Apr;35(4):719-25. doi: 10.1007/s00296-014-3144-6. Epub 2014 Oct 5. Rheumatol Int. 2015. PMID: 25284376
-
TWEAK/Fn14 Activation Participates in Skin Inflammation.Mediators Inflamm. 2017;2017:6746870. doi: 10.1155/2017/6746870. Epub 2017 Sep 6. Mediators Inflamm. 2017. PMID: 29038621 Free PMC article. Review.
-
Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.Trials. 2020 Apr 28;21(1):362. doi: 10.1186/s13063-020-04285-3. Trials. 2020. PMID: 32345372 Free PMC article.
-
Vasculitis syndromes: A closer look at skin involvement in vasculitis.Nat Rev Rheumatol. 2018 Apr;14(4):186-187. doi: 10.1038/nrrheum.2018.26. Epub 2018 Feb 22. Nat Rev Rheumatol. 2018. PMID: 29467450 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical